Taiwan To Continue Listing Some Vitamins as Drug Products
This article was originally published in PharmAsia News
Taiwan's health department says it will continue listing certain vitamins and other treatments as drug products. The Department of Health currently lists vitamins that are injected, have a high dosage, are single prescriptions or claim treatment effects. As an example, officials cited vitamin D as a natural substance, but D3 is not, so a calcium tablet with that element is regarded as a drug product. The decision was announced at a meeting with experts on listing vitamins as food products. (Click here for more
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?